Table 2 Characteristics of HCC patients at the post-treatment and recurrence.
Characteristics of patients | Value |
|---|---|
Laboratory Data (post-treatment) | |
T-BIL (mg/dL) | 1.04 (0.4–2.5) |
AST (IU/L) | 40.7 (21–96) |
ALT (IU/L) | 32.7 (5–118) |
ALB (g/dL) | 3.47 (2.7–4.3) |
PT (%) | 102.3 (61–120) |
WBC (/L) | 4150 (2299–8500) |
Hb (g/dL) | 11.1 (8.8–13.6) |
PLT (103/L) | 144 (36–387) |
AFP (ng/mL) | 109.4 (2.3–568) |
AFP-L3 (%) | 14.5 (0.5–78.9) |
PIVKA II (mAU/mL) | 206.8 (10–1920) |
Laboratory Data (recurrence) | |
T-BIL (mg/dL) | 1.36 (0.4–2.9) |
AST (IU/L) | 60.2 (18–145) |
ALT (IU/L) | 47.9 (13–135) |
ALB (g/dL) | 3.25 (2–4.2) |
PT (%) | 79.6 (60–120) |
WBC (/L) | 3763 (1600–6400) |
Hb (g/dL) | 13.0 (9.8–16.1) |
PLT (103/L) | 102.9 (39–318) |
AFP (ng/mL) | 1003.0 (6.1–15099) |
AFP-L3 (%) | 30.2 (0.5–78.5) |
PIVKA II (mAU/mL) | 643.5 (13–7530) |
